Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Orgenesis ( (ORGS) ) has provided an update.
On August 21, Ashish Nanda resigned as a director of Orgenesis Inc., effective immediately. His resignation was not due to any disagreements with the company’s operations or management, and the company expressed gratitude for his contributions.
Spark’s Take on ORGS Stock
According to Spark, TipRanks’ AI Analyst, ORGS is a Underperform.
Orgenesis faces substantial financial challenges, with negative revenue and cash flow issues indicating significant instability. Despite negative technical indicators, recent corporate governance improvements may provide a slight strategic advantage. However, these factors are overshadowed by the company’s overarching financial distress, resulting in a low overall stock score.
To see Spark’s full report on ORGS stock, click here.
More about Orgenesis
Average Trading Volume: 3,530
Technical Sentiment Signal: Sell
Current Market Cap: $516.9K
For an in-depth examination of ORGS stock, go to TipRanks’ Overview page.